谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Decrease in Fecal Calprotectin and C-reactive Protein Levels Correlate with Improved Clinical Outcomes in Patients with Moderately to Severely Active Crohn's Disease Treated with Mirikizumab

A. Charabaty,M. Kayal, C. R. Kelly,B. L. Cohen,G. D'Haens,A. Hart, F. Chan-Diehl, G. Yu, Y. Brogan,M. Protic, R. Moses, D. Fisher,S. Travis

JOURNAL OF CROHNS & COLITIS（2025）

引用 0|浏览4
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要